CLOV:NSD-Clover Health Investments Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 4.24

Change

+0.16 (+3.92)%

Market Cap

USD 1.82B

Volume

6.72M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-21 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
ALHC Alignment Healthcare LLC

-0.01 (-0.07%)

USD 2.28B
MRAI Marpai Inc

-0.02 (-2.00%)

USD 0.01B

ETFs Containing CLOV

XHS SPDR® S&P Health Care Se.. 2.52 % 0.35 %

+2.59 (+2.69%)

USD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 34.60% 100% F 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.60% 100% F 95% A
Trailing 12 Months  
Capital Gain 325.28% 100% F 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 325.28% 100% F 98% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -5.87% 100% F 26% F
Dividend Return -5.87% 100% F 25% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 89.64% 67% D+ 24% F
Risk Adjusted Return -6.55% 100% F 30% F
Market Capitalization 1.82B 67% D+ 78% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.